Spark Therapeutics Stock Price (NASDAQ:ONCE)

Add to My Stocks
$59.94 $0.54 (0.89%) ONCE stock closing price Feb 24, 2017 (Closing)
Spark Therapeutics
24 FEB 2017
amigobulls logo
ONCE hand_up
ONCE vs S&P 500
Closing Price: Feb 24, 2017
$59.94 ( -0.89%)
S&P 500
2367.3 ( 0.15%)
52 Week Price Range
1 Year Return: 89%
Q3 Growth*
Profitable ?
net image
2016 Q3 Net Loss
home image
☆ ☆ ☆ ☆ ☆★ ★ ★ ★ ★
Double Tap To Exit Full Screen

Spark Therapeutics Snapshot Video

12 5 2

ONCE Stock Details

Prev Close* : $60.48
Market Cap:
Day Low: $58.17
52 Week Low: $28.38
Open: $59.68
Volume: 309226
Day High: $60.77
52 Week High: $65.99

Latest Stock Market News

Latest Articles

Spark Therapeutics News - From Partners

ONCE Stockcharts

View ONCE PE ratio, PS ratio stocks charts and compare with peers.
ONCE Chart
Note: Compare Spark Therapeutics stock price history with the index and industry peers.

Spark Therapeutics Valuation

PS ratio (
price to sales ratio
PB ratio (
price to book ratio

Spark Therapeutics Financial Ratios

Asset Turnover
Receivables Turnover

ONCE Industry Peers

Company Price Change (%)
Array Biopharma (ARRY)10.560.2 (1.93%)
Kythera Biopharma (KYTH)74.980 (0%)
Dimension Therapeutics (DMTX)1.680.07 (4%)
Pfizer (PFE)34.260.2 (0.59%)
Baxalta (BXLT)46.020.18 (0.39%)
Sangamo Biosciences (SGMO)40.15 (3.9%)
Regenxbio (RGNX)17.350.3 (1.76%)

Top Stock Gainers

show top losers
CompanyPriceChange (%)
Incyte (INCY)131.219.26 (7.59%)
Sarepta Therapeutics (SRPT)32.021.87 (6.2%)
Stemline Therapeutics (STML)6.850.4 (6.2%)
Bluebird Bio (BLUE)823.7 (4.73%)
Puma Biotech (PBYI)36.21.5 (4.32%)
Sangamo BioSciences (SGMO)40.15 (3.9%)
Epizyme (EPZM)12.150.45 (3.85%)
Top gainers from Medical-Biomed-Genetics industry
* As of Feb 25, 2017
CompanyPriceChange (%)
Achillion Pharma (ACHN)3.860.38 (8.96%)
Chromadex (CDXC)2.740.13 (4.53%)
Idera Pharma (IDRA)1.670.06 (3.47%)
Inovio Pharma (INO)6.680.22 (3.19%)
VIVUS (VVUS)1.140.03 (2.56%)
Ligand Pharma (LGND)100.382.46 (2.39%)
Compugen (CGEN)4.30.1 (2.27%)
Top losers from Medical-Biomed-Genetics industry
* As of Feb 25, 2017

Spark Therapeutics Financial Statements

income statement201520142013
Net Sales Or Revenues22.06M0.63M-
Net Income-47.12M-24.32M-57.27M
Total Operating Expense69.37M24.96M57.27M
view Spark Therapeutics Inc income statement
balance sheet201520142013
Total Assets329.77M90.44M4.86M
Total Liabilities39.23M35.24M1.49M
Shareholders Equity290.53M55.2M3.36M
view Spark Therapeutics Inc balance sheet
cash flow statement201520142013
Net Increase (Decrease) In Assets Liabilities-15.83M30.19M1.49M
Net Cash From (Used By) Operating Activities-47.47M10.38M-5.13M
Increase (Decrease) In Prop Plant And Equipment-4.52M-11.69M-
view Spark Therapeutics Inc cashflow statement

Spark Therapeutics Inc Stock News - Partner Headlines

Spark Therapeutics Stock Message Board

An investor needs to spend 59.94 to buy ONCE stock, as the closing Spark Therapeutics stock price is 59.94. The total market value as denoted by 1.86B for Spark Therapeutics, is the market value of the company's outstanding shares. A value investor must look at the fundamentals of a stock, and perform Spark Therapeutics valuation, even though in the short-term sentiment and current breaking news might affect Spark Therapeutics stock price.

The terms stocks and shares mean the same thing. For Ex: Spark Therapeutics stock price and Spark Therapeutics share price mean the same thing. 309226 ONCE shares were traded yesterday, and Spark Therapeutics stock chart shows that the ONCE stock quote hit a day high of 60.77 and day low of 58.17. A dividend is a cash payment from a company's earnings and is distributed among shareholders. Spark Therapeutics does not pay dividends. Spark Therapeutics stock price history, gives the entire historical data for ONCE stock.